ARCHIVES

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

This article is from The Cancer Letter archive.

Vol. 30 No. 2 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993

In Brief: Winston Ho Heads Saint Joseph Bone Marrow Transplant Unit; Smoking Cost $452 Bil. A Year

March 16, 1990

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

PDQ Needs Change, Advocates Say, NBCC to Build Its Own Trials Registry

October 11, 1996